Personal tools

DOID:8552: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 1: Line 1:
{{DOID
{{DOID
|id=DOID:8552
|alt_id=DOID:8551;;DOID:8606
|name=chronic myeloid leukemia
|namespace=disease_ontology
|def=
|xref=ICD9CM:205.1;;MSH:D015464;;NCI:C3174;;OMIM:608232;;SNOMEDCT_2010_1_31:154592009;;SNOMEDCT_2010_1_31:188735005;;SNOMEDCT_2010_1_31:63364005;;SNOMEDCT_2010_1_31:92818009;;UMLS_CUI:C0023473
|is_a=DOID:8692
|synonym="chronic myelogenous leukemia, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:63364005];;"chronic myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:154592009];;"chronic myeloid leukemia in remission" EXACT [];;"chronic myeloid leukemia in remission (disorder)" EXACT [SNOMEDCT_2005_07_31:92817004];;"chronic myeloid leukemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188735005];;"chronic myeloid leukemia without mention of remission" EXACT [];;"chronic myeloid leukemia, disease (disorder)" EXACT [SNOMEDCT_2005_07_31:92818009];;"CML" EXACT [CSP2005:2004-1700];;"CML - chronic Myelogenous Leukemia" EXACT [NCI2004_11_17:C3174];;"CML in Remission" EXACT [NCI2004_11_17:C3589];;"Myeloid Leukemia, chronic" EXACT [MTH:NOCODE]
|comment=OMIM mapping confirmed by DO. [SN].
|comment=OMIM mapping confirmed by DO. [SN].
|alt_id=DOID:8551;;DOID:8606
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def=
|subset=
|derives_from=
|derives_from=
|develops_from=
|develops_from=
|disjoint_from=
|has_quality=
|has_quality=
|id=DOID:8552
|is_a=DOID:8692
|is_obsolete=
|located_in=
|located_in=
|name=chronic myeloid leukemia
|namespace=disease_ontology
|obo_creation_date=
|part_of=
|part_of=
|preceded_by=
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|is_obsolete=
|subset=
|preceded_by=
|synonym="chronic myelogenous leukemia, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:63364005];;"chronic myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:154592009];;"chronic myeloid leukemia in remission" EXACT [];;"chronic myeloid leukemia in remission (disorder)" EXACT [SNOMEDCT_2005_07_31:92817004];;"chronic myeloid leukemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188735005];;"chronic myeloid leukemia without mention of remission" EXACT [];;"chronic myeloid leukemia, disease (disorder)" EXACT [SNOMEDCT_2005_07_31:92818009];;"CML" EXACT [CSP2005:2004-1700];;"CML - chronic Myelogenous Leukemia" EXACT [NCI2004_11_17:C3174];;"CML in Remission" EXACT [NCI2004_11_17:C3589];;"Myeloid Leukemia, chronic" EXACT [MTH:NOCODE]
|union_of=
|xref=ICD9CM:205.1;;MSH:D015464;;NCI:C3174;;OMIM:608232;;SNOMEDCT_2010_1_31:154592009;;SNOMEDCT_2010_1_31:188735005;;SNOMEDCT_2010_1_31:63364005;;SNOMEDCT_2010_1_31:92818009;;UMLS_CUI:C0023473
}}
}}

Revision as of 10:36, 12 September 2014

Name:chronic myeloid leukemia
Namespace:disease_ontology
Xrefs:
links:

ICD9CM:205.1
MSH:D015464
NCI:C3174
OMIM:608232
SNOMEDCT_2010_1_31:154592009
SNOMEDCT_2010_1_31:188735005
SNOMEDCT_2010_1_31:63364005
SNOMEDCT_2010_1_31:92818009

UMLS_CUI:C0023473
Synonyms: "chronic myelogenous leukemia, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:63364005]
"chronic myeloid leukaemia" EXACT [SNOMEDCT_2005_07_31:154592009]
"chronic myeloid leukemia in remission" EXACT []
"chronic myeloid leukemia in remission (disorder)" EXACT [SNOMEDCT_2005_07_31:92817004]
"chronic myeloid leukemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188735005]
"chronic myeloid leukemia without mention of remission" EXACT []
"chronic myeloid leukemia, disease (disorder)" EXACT [SNOMEDCT_2005_07_31:92818009]
"CML" EXACT [CSP2005:2004-1700]
"CML - chronic Myelogenous Leukemia" EXACT [NCI2004_11_17:C3174]
"CML in Remission" EXACT [NCI2004_11_17:C3589]
"Myeloid Leukemia, chronic" EXACT [MTH:NOCODE]
Comments:OMIM mapping confirmed by DO. [SN].
Alt_id: DOID:8551
DOID:8606

Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data

Parents

is_a:DOID:8692(myeloid leukemia)



Children


is a:FF:10766-110F1 (chronic myelogenous leukemia (CML) cell line:MEG-A2),FF:10769-110F4 ()

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

Mouse (Mus musculus)

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:8552 (chronic myeloid leukemia), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

P-valueFFCPShort description
5.42e-195FFCP PHASE1:Hg19::chr11:119994013..119994021,-#_d6a39d8ba9edb33f1f1d6362231178abp50@TRIM29
5.42e-195FFCP PHASE2:Hg19::chr11:119994013..119994021,-#_d6a39d8ba9edb33f1f1d6362231178abp50@TRIM29
9.37e-99FFCP PHASE1:Hg19::chr11:59866802..59866805,-#_e1a926889fe3875f9d7838bf0a373219p@chr11:59866802..59866805, -
9.37e-99FFCP PHASE2:Hg19::chr11:59866802..59866805,-#_e1a926889fe3875f9d7838bf0a373219p@chr11:59866802..59866805, -
2.55e-98FFCP PHASE1:Hg19::chr11:66469256..66469259,-#_a4bc0d72186e06bb8f9a0fcdf8d14702p@chr11:66469256..66469259, -
2.55e-98FFCP PHASE2:Hg19::chr11:66469256..66469259,-#_a4bc0d72186e06bb8f9a0fcdf8d14702p@chr11:66469256..66469259, -
1.23e-66FFCP PHASE1:Hg19::chr3:195603532..195603537,-#_a37c994cd023b9090a89e95d76f5e066p30@TNK2
1.23e-66FFCP PHASE1:Hg19::chr11:13804110..13804121,-#_a37c994cd023b9090a89e95d76f5e066p@chr11:13804110..13804121, -
1.23e-66FFCP PHASE2:Hg19::chr11:13804110..13804121,-#_a37c994cd023b9090a89e95d76f5e066p@chr11:13804110..13804121, -
1.23e-66FFCP PHASE2:Hg19::chr3:195603532..195603537,-#_a37c994cd023b9090a89e95d76f5e066p30@TNK2
1.23e-66FFCP PHASE1:Hg19::chr13:52569530..52569556,-#_a37c994cd023b9090a89e95d76f5e066p@chr13:52569530..52569556, -
1.23e-66FFCP PHASE2:Hg19::chr13:52569530..52569556,-#_a37c994cd023b9090a89e95d76f5e066p@chr13:52569530..52569556, -
2.39e-66FFCP PHASE2:Hg19::chr1:236205360..236205375,-#_040a89978addb73db375564d08ace6f9p@chr1:236205360..236205375, -
2.39e-66FFCP PHASE1:Hg19::chr10:127505042..127505063,-#_040a89978addb73db375564d08ace6f9p8@UROS
2.39e-66FFCP PHASE2:Hg19::chr10:127505042..127505063,-#_040a89978addb73db375564d08ace6f9p8@UROS
2.39e-66FFCP PHASE1:Hg19::chr1:236205360..236205375,-#_040a89978addb73db375564d08ace6f9p@chr1:236205360..236205375, -
4.66e-66FFCP PHASE1:Hg19::chr5:91016062..91016069,+#_5949dad40a9d7e48e1836c20e14be7dep@chr5:91016062..91016069, +
4.66e-66FFCP PHASE2:Hg19::chr5:91016062..91016069,+#_5949dad40a9d7e48e1836c20e14be7dep@chr5:91016062..91016069, +
4.66e-66FFCP PHASE1:Hg19::chr11:5264728..5264739,-#_5949dad40a9d7e48e1836c20e14be7dep5@HBBP1
4.66e-66FFCP PHASE2:Hg19::chr11:5264728..5264739,-#_5949dad40a9d7e48e1836c20e14be7dep5@HBBP1
1.46e-50FFCP PHASE1:Hg19::chr1:6214945..6214961,-#_fd0cb77100dbffab3ac58d9f5fbe40aap@chr1:6214945..6214961, -
1.46e-50FFCP PHASE2:Hg19::chr7:150654795..150654806,-#_fd0cb77100dbffab3ac58d9f5fbe40aap@chr7:150654795..150654806, -
1.46e-50FFCP PHASE2:Hg19::chr1:6214945..6214961,-#_fd0cb77100dbffab3ac58d9f5fbe40aap@chr1:6214945..6214961, -
1.46e-50FFCP PHASE1:Hg19::chr7:150654795..150654806,-#_fd0cb77100dbffab3ac58d9f5fbe40aap@chr7:150654795..150654806, -
2.42e-50FFCP PHASE2:Hg19::chr11:36119908..36119916,+#_9ac2a84173ac1f197315f23db3b99b98p7@LDLRAD3
2.42e-50FFCP PHASE2:Hg19::chr6:132000668..132000670,+#_9ac2a84173ac1f197315f23db3b99b98p@chr6:132000668..132000670, +
2.42e-50FFCP PHASE1:Hg19::chr6:132000668..132000670,+#_9ac2a84173ac1f197315f23db3b99b98p@chr6:132000668..132000670, +
2.42e-50FFCP PHASE1:Hg19::chr11:36119908..36119916,+#_9ac2a84173ac1f197315f23db3b99b98p7@LDLRAD3
3.99e-50FFCP PHASE1:Hg19::chr4:175439176..175439186,-#_dfe9f8fd1d02af1c9ad8f3f8bd9ac237p@chr4:175439176..175439186, -
3.99e-50FFCP PHASE2:Hg19::chr1:25747423..25747428,-#_dfe9f8fd1d02af1c9ad8f3f8bd9ac237p3@RHCE
3.99e-50FFCP PHASE1:Hg19::chr1:25747423..25747428,-#_dfe9f8fd1d02af1c9ad8f3f8bd9ac237p3@RHCE
3.99e-50FFCP PHASE2:Hg19::chr4:175439176..175439186,-#_dfe9f8fd1d02af1c9ad8f3f8bd9ac237p@chr4:175439176..175439186, -
6.58e-50FFCP PHASE1:Hg19::chr11:36119758..36119765,+#_f13ad4fec0ce597ff273b4eed267f8acp9@LDLRAD3
6.58e-50FFCP PHASE2:Hg19::chr11:36119758..36119765,+#_f13ad4fec0ce597ff273b4eed267f8acp9@LDLRAD3
6.62e-41FFCP PHASE1:Hg19::chr13:52568084..52568091,-#_e1f792dbb2f9f823ffdb95b3be222bc8p@chr13:52568084..52568091, -
6.62e-41FFCP PHASE2:Hg19::chr13:52568084..52568091,-#_e1f792dbb2f9f823ffdb95b3be222bc8p@chr13:52568084..52568091, -
6.62e-41FFCP PHASE1:Hg19::chr11:5264923..5264932,-#_e1f792dbb2f9f823ffdb95b3be222bc8p6@HBBP1
6.62e-41FFCP PHASE2:Hg19::chr11:5264923..5264932,-#_e1f792dbb2f9f823ffdb95b3be222bc8p6@HBBP1
9.91e-41FFCP PHASE1:Hg19::chr11:36119803..36119812,+#_0bb25e852fd7d29f66be25497ca958c2p6@LDLRAD3
9.91e-41FFCP PHASE2:Hg19::chr11:36119803..36119812,+#_0bb25e852fd7d29f66be25497ca958c2p6@LDLRAD3
9.91e-41FFCP PHASE1:Hg19::chrX:109564494..109564506,-#_0bb25e852fd7d29f66be25497ca958c2p@chrX:109564494..109564506, -
9.91e-41FFCP PHASE2:Hg19::chr2:190448096..190448099,-#_0bb25e852fd7d29f66be25497ca958c2p15@SLC40A1
9.91e-41FFCP PHASE2:Hg19::chrX:81069119..81069129,+#_0bb25e852fd7d29f66be25497ca958c2p@chrX:81069119..81069129, +
9.91e-41FFCP PHASE1:Hg19::chr2:190448096..190448099,-#_0bb25e852fd7d29f66be25497ca958c2p15@SLC40A1
9.91e-41FFCP PHASE2:Hg19::chrX:109564494..109564506,-#_0bb25e852fd7d29f66be25497ca958c2p@chrX:109564494..109564506, -
9.91e-41FFCP PHASE1:Hg19::chrX:81069119..81069129,+#_0bb25e852fd7d29f66be25497ca958c2p@chrX:81069119..81069129, +
1.48e-40FFCP PHASE1:Hg19::chr5:3778511..3778555,+#_96de7cb401c3b6de6a3f72b1fb42d2dfp@chr5:3778511..3778555, +
1.48e-40FFCP PHASE1:Hg19::chr5:134812717..134812721,+#_96de7cb401c3b6de6a3f72b1fb42d2dfp@chr5:134812717..134812721, +
1.48e-40FFCP PHASE2:Hg19::chr3:55001120..55001131,-#_96de7cb401c3b6de6a3f72b1fb42d2dfp6@LRTM1
1.48e-40FFCP PHASE1:Hg19::chr10:17462911..17462917,-#_96de7cb401c3b6de6a3f72b1fb42d2dfp@chr10:17462911..17462917, -
1.48e-40FFCP PHASE2:Hg19::chr10:17462911..17462917,-#_96de7cb401c3b6de6a3f72b1fb42d2dfp@chr10:17462911..17462917, -
1.48e-40FFCP PHASE1:Hg19::chr3:55001120..55001131,-#_96de7cb401c3b6de6a3f72b1fb42d2dfp6@LRTM1
1.48e-40FFCP PHASE2:Hg19::chr4:175412395..175412407,-#_96de7cb401c3b6de6a3f72b1fb42d2dfp@chr4:175412395..175412407, -
1.48e-40FFCP PHASE2:Hg19::chr5:3778511..3778555,+#_96de7cb401c3b6de6a3f72b1fb42d2dfp@chr5:3778511..3778555, +
1.48e-40FFCP PHASE2:Hg19::chr5:134812717..134812721,+#_96de7cb401c3b6de6a3f72b1fb42d2dfp@chr5:134812717..134812721, +
1.48e-40FFCP PHASE1:Hg19::chr4:175412395..175412407,-#_96de7cb401c3b6de6a3f72b1fb42d2dfp@chr4:175412395..175412407, -
2.21e-40FFCP PHASE2:Hg19::chr8:55013587..55013594,-#_975a805650b1bcc92ad75c8440954cafp@chr8:55013587..55013594, -
2.21e-40FFCP PHASE1:Hg19::chr8:55013587..55013594,-#_975a805650b1bcc92ad75c8440954cafp@chr8:55013587..55013594, -
2.21e-40FFCP PHASE1:Hg19::chr11:36119770..36119780,+#_975a805650b1bcc92ad75c8440954cafp8@LDLRAD3
2.21e-40FFCP PHASE2:Hg19::chr11:36119770..36119780,+#_975a805650b1bcc92ad75c8440954cafp8@LDLRAD3
3.3e-40FFCP PHASE1:Hg19::chr10:129780357..129780368,+#_a38e10d8d12a924b7efef4fb0e2248f1p@chr10:129780357..129780368, +
3.3e-40FFCP PHASE2:Hg19::chr10:129780357..129780368,+#_a38e10d8d12a924b7efef4fb0e2248f1p@chr10:129780357..129780368, +
3.3e-40FFCP PHASE1:Hg19::chr13:109248291..109248311,+#_a38e10d8d12a924b7efef4fb0e2248f1p10@MYO16
3.3e-40FFCP PHASE2:Hg19::chr13:109248291..109248311,+#_a38e10d8d12a924b7efef4fb0e2248f1p10@MYO16
3.3e-40FFCP PHASE1:Hg19::chr11:57154881..57154893,+#_a38e10d8d12a924b7efef4fb0e2248f1p1@CU675194
3.3e-40FFCP PHASE2:Hg19::chr11:57154881..57154893,+#_a38e10d8d12a924b7efef4fb0e2248f1p1@CU675194
3.3e-40FFCP PHASE2:Hg19::chr8:55013619..55013630,-#_a38e10d8d12a924b7efef4fb0e2248f1p@chr8:55013619..55013630, -
3.3e-40FFCP PHASE1:Hg19::chr8:55013619..55013630,-#_a38e10d8d12a924b7efef4fb0e2248f1p@chr8:55013619..55013630, -
1.84e-34FFCP PHASE1:Hg19::chr12:110211298..110211309,-#_bd525fad8b1c919ea8006b8377513a54p1@ENST00000541723
1.84e-34FFCP PHASE2:Hg19::chr12:110211298..110211309,-#_bd525fad8b1c919ea8006b8377513a54p1@ENST00000541723
1.84e-34FFCP PHASE1:Hg19::chr11:59876093..59876098,-#_bd525fad8b1c919ea8006b8377513a54p@chr11:59876093..59876098, -
1.84e-34FFCP PHASE2:Hg19::chr11:59876093..59876098,-#_bd525fad8b1c919ea8006b8377513a54p@chr11:59876093..59876098, -
2.58e-34FFCP PHASE1:Hg19::chr6:39160057..39160060,-#_9db85212ac53a057aec0c02d367dc9f6p@chr6:39160057..39160060, -
2.58e-34FFCP PHASE2:Hg19::chr2:68524697..68524699,-#_9db85212ac53a057aec0c02d367dc9f6p12@CNRIP1
2.58e-34FFCP PHASE1:Hg19::chr11:128132940..128132950,+#_9db85212ac53a057aec0c02d367dc9f6p@chr11:128132940..128132950, +
2.58e-34FFCP PHASE1:Hg19::chr12:16968439..16968442,-#_9db85212ac53a057aec0c02d367dc9f6p@chr12:16968439..16968442, -
2.58e-34FFCP PHASE2:Hg19::chr11:128132940..128132950,+#_9db85212ac53a057aec0c02d367dc9f6p@chr11:128132940..128132950, +
2.58e-34FFCP PHASE2:Hg19::chr6:156941231..156941245,-#_9db85212ac53a057aec0c02d367dc9f6p@chr6:156941231..156941245, -
2.58e-34FFCP PHASE2:Hg19::chr12:16968439..16968442,-#_9db85212ac53a057aec0c02d367dc9f6p@chr12:16968439..16968442, -
2.58e-34FFCP PHASE2:Hg19::chr2:190448106..190448113,-#_9db85212ac53a057aec0c02d367dc9f6p14@SLC40A1
2.58e-34FFCP PHASE1:Hg19::chr2:68524697..68524699,-#_9db85212ac53a057aec0c02d367dc9f6p12@CNRIP1
2.58e-34FFCP PHASE2:Hg19::chr6:39160057..39160060,-#_9db85212ac53a057aec0c02d367dc9f6p@chr6:39160057..39160060, -
2.58e-34FFCP PHASE2:Hg19::chr1:35309235..35309266,-#_9db85212ac53a057aec0c02d367dc9f6p@chr1:35309235..35309266, -
2.58e-34FFCP PHASE1:Hg19::chr6:156941231..156941245,-#_9db85212ac53a057aec0c02d367dc9f6p@chr6:156941231..156941245, -
2.58e-34FFCP PHASE1:Hg19::chr2:190448106..190448113,-#_9db85212ac53a057aec0c02d367dc9f6p14@SLC40A1
2.58e-34FFCP PHASE1:Hg19::chr1:35309235..35309266,-#_9db85212ac53a057aec0c02d367dc9f6p@chr1:35309235..35309266, -
3.61e-34FFCP PHASE2:Hg19::chr1:19939761..19939796,-#_c9f5da2d8b836a5a1a933701d0629579p@chr1:19939761..19939796, -
3.61e-34FFCP PHASE2:Hg19::chr4:139694701..139694704,+#_c9f5da2d8b836a5a1a933701d0629579p1@ENST00000502606
3.61e-34FFCP PHASE1:Hg19::chr19:17392513..17392520,+#_c9f5da2d8b836a5a1a933701d0629579p5@ANKLE1
3.61e-34FFCP PHASE1:Hg19::chr4:139694701..139694704,+#_c9f5da2d8b836a5a1a933701d0629579p1@ENST00000502606
3.61e-34FFCP PHASE1:Hg19::chr1:19939761..19939796,-#_c9f5da2d8b836a5a1a933701d0629579p@chr1:19939761..19939796, -
3.61e-34FFCP PHASE2:Hg19::chr19:17392513..17392520,+#_c9f5da2d8b836a5a1a933701d0629579p5@ANKLE1
5.05e-34FFCP PHASE1:Hg19::chr9:135730367..135730374,-#_fc51a8c22ce3e421c50fd7d36ffe10e7p@chr9:135730367..135730374, -
5.05e-34FFCP PHASE2:Hg19::chr4:74281935..74281942,+#_fc51a8c22ce3e421c50fd7d36ffe10e7p34@ALB
5.05e-34FFCP PHASE2:Hg19::chr8:141312919..141312935,-#_fc51a8c22ce3e421c50fd7d36ffe10e7p8@TRAPPC9
5.05e-34FFCP PHASE1:Hg19::chr4:74281935..74281942,+#_fc51a8c22ce3e421c50fd7d36ffe10e7p34@ALB
5.05e-34FFCP PHASE2:Hg19::chr9:135730367..135730374,-#_fc51a8c22ce3e421c50fd7d36ffe10e7p@chr9:135730367..135730374, -
5.05e-34FFCP PHASE1:Hg19::chr8:141312919..141312935,-#_fc51a8c22ce3e421c50fd7d36ffe10e7p8@TRAPPC9
7.06e-34FFCP PHASE1:Hg19::chr11:57156114..57156132,-#_b329f13b119aae61045347cfd90c9392p@chr11:57156114..57156132, -
7.06e-34FFCP PHASE1:Hg19::chr6:29447609..29447623,+#_b329f13b119aae61045347cfd90c9392p@chr6:29447609..29447623, +

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=DOID:8552&oldid=3272399"